Empagliflozin improves clinical outcomes for HFpEF in EMPEROR-Preserved
Abstract
In a clinical first, empagliflozin treatment cuts the risk of cardiovascular death and hospitalization compared with placebo in patients with heart failure with preserved ejection...
Paper Details
Title
Empagliflozin improves clinical outcomes for HFpEF in EMPEROR-Preserved
Published Date
Sep 15, 2021
Journal
Volume
18
Issue
11
Pages
737 - 737
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History